Naruhiko Mizuta

872 total citations
44 papers, 683 citations indexed

About

Naruhiko Mizuta is a scholar working on Molecular Biology, Oncology and Surgery. According to data from OpenAlex, Naruhiko Mizuta has authored 44 papers receiving a total of 683 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Molecular Biology, 17 papers in Oncology and 16 papers in Surgery. Recurrent topics in Naruhiko Mizuta's work include Breast Cancer Treatment Studies (13 papers), Cell death mechanisms and regulation (9 papers) and Breast Implant and Reconstruction (9 papers). Naruhiko Mizuta is often cited by papers focused on Breast Cancer Treatment Studies (13 papers), Cell death mechanisms and regulation (9 papers) and Breast Implant and Reconstruction (9 papers). Naruhiko Mizuta collaborates with scholars based in Japan, South Korea and United States. Naruhiko Mizuta's co-authors include Ikuya Fujiwara, Hiroo Nakajima, Satoru Hashimoto, Yoshihiro Kitamura, Kunihiko Kooguchi, Koichi Sakaguchi, Atsuko Kobayashi, Junji Magae, Hiroshi Nakajima and Kiyoshi Sawai and has published in prestigious journals such as Journal of Clinical Oncology, American Journal of Respiratory and Critical Care Medicine and Oncogene.

In The Last Decade

Naruhiko Mizuta

42 papers receiving 670 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Naruhiko Mizuta Japan 15 252 187 169 157 143 44 683
Huifang Zhou China 17 265 1.1× 217 1.2× 182 1.1× 209 1.3× 189 1.3× 41 794
Nadia Kourda Tunisia 16 188 0.7× 170 0.9× 130 0.8× 134 0.9× 145 1.0× 60 699
Zhifang Jia China 19 329 1.3× 207 1.1× 179 1.1× 239 1.5× 232 1.6× 57 953
Andrea Beer Austria 18 161 0.6× 201 1.1× 96 0.6× 167 1.1× 142 1.0× 40 751
Oksana Kowalczuk Poland 15 215 0.9× 76 0.4× 136 0.8× 143 0.9× 97 0.7× 51 720
Chun‐I Wang Taiwan 17 374 1.5× 177 0.9× 120 0.7× 47 0.3× 144 1.0× 50 913
Ying Tian China 16 347 1.4× 100 0.5× 177 1.0× 90 0.6× 112 0.8× 40 686
Xiaojun Zhu China 20 303 1.2× 124 0.7× 184 1.1× 261 1.7× 118 0.8× 70 905
Uwe Ramp Germany 14 370 1.5× 138 0.7× 121 0.7× 56 0.4× 184 1.3× 32 656

Countries citing papers authored by Naruhiko Mizuta

Since Specialization
Citations

This map shows the geographic impact of Naruhiko Mizuta's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Naruhiko Mizuta with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Naruhiko Mizuta more than expected).

Fields of papers citing papers by Naruhiko Mizuta

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Naruhiko Mizuta. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Naruhiko Mizuta. The network helps show where Naruhiko Mizuta may publish in the future.

Co-authorship network of co-authors of Naruhiko Mizuta

This figure shows the co-authorship network connecting the top 25 collaborators of Naruhiko Mizuta. A scholar is included among the top collaborators of Naruhiko Mizuta based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Naruhiko Mizuta. Naruhiko Mizuta is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Konishi, Eiichi, Isao Yokota, Shogen Boku, et al.. (2024). Additional statin treatment enhances the efficacy of HER2 blockade and improves prognosis in Rac1-high/HER2-positive breast cancer. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1870(8). 167458–167458. 2 indexed citations
2.
Nakatsukasa, Katsuhiko, Hiroshi Koyama, Naruhiko Mizuta, et al.. (2016). Docetaxel and cyclophosphamide as neoadjuvant chemotherapy in HER2-negative primary breast cancer. Breast Cancer. 24(1). 63–68. 33 indexed citations
3.
Fujita, Yoshifumi, Naruhiko Mizuta, Koichi Sakaguchi, et al.. (2012). [A case of effective lapatinib/capecitabine therapy for HER2-positive breast cancer with multiple brain metastases].. PubMed. 39(11). 1699–702. 1 indexed citations
4.
Sakaguchi, Koichi, et al.. (2012). [Administration of nab-paclitaxel for 9 metastatic breast cancer patients].. PubMed. 39(7). 1081–5.
5.
Mizuta, Naruhiko, et al.. (2011). [A case of effective combination therapy with docetaxel, cyclophosphamide and trastuzumab as primary systemic therapy for locally advanced HER2-positive breast cancer].. PubMed. 38(9). 1491–4.
6.
Fujiwara, Ikuya, et al.. (2009). Video-assisted skin-sparing breast-conserving surgery for breast cancer and immediate reconstruction with autologous tissue: Clinical outcomes. Journal of Clinical Oncology. 27(15_suppl). e11580–e11580. 1 indexed citations
7.
Nakajima, Hiroo, Ikuya Fujiwara, Naruhiko Mizuta, et al.. (2008). Prognosis of Japanese Breast Cancer Based on Hormone Receptor and HER2 Expression Determined by Immunohistochemical Staining. World Journal of Surgery. 32(11). 2477–2482. 9 indexed citations
8.
Sakaguchi, Koichi, et al.. (2008). . Nihon Nyugan Kenshin Gakkaishi (Journal of Japan Association of Breast Cancer Screening). 17(2). 154–160. 1 indexed citations
9.
Nakajima, Hiroo, Naruhiko Mizuta, Yoshihiro Kitamura, et al.. (2008). Fas Ligand Released by Activated Monocytes Causes Apoptosis of Lung Epithelial Cells in Human Acute Lung Injury Model in Vitro. Biological and Pharmaceutical Bulletin. 31(3). 386–390. 20 indexed citations
10.
Nakajima, Hiroo, Ikuya Fujiwara, Naruhiko Mizuta, et al.. (2007). INVESTIGATION OF THE PROGNOSIS OF BREAST CANCER FROM THE VIEW POINT OF PRESENTATION OF ESTROGEN RECEPTOR AND HER2 IN IMMUNOHISTOCHEMICAL STAINING. Nihon Rinsho Geka Gakkai Zasshi (Journal of Japan Surgical Association). 68(9). 2171–2177. 2 indexed citations
11.
Sawai, Kiyoshi, et al.. (2007). . Nihon Nyugan Kenshin Gakkaishi (Journal of Japan Association of Breast Cancer Screening). 16(1). 38–43. 1 indexed citations
12.
Nakajima, Hiroo, Naruhiko Mizuta, Koichi Sakaguchi, et al.. (2007). Development of HER2-antagonistic peptides as novel anti-breast cancer drugs by in silico methods. Breast Cancer. 15(1). 65–72. 21 indexed citations
13.
Nakajima, Hiroo, Naruhiko Mizuta, Katsuhiko Nakatsukasa, et al.. (2006). [A case of multi-drug resistant recurrent breast cancer with multiple bone metastasis responding to TS-1 and trastuzumab].. PubMed. 33(9). 1305–8. 1 indexed citations
14.
Sawai, Kiyoshi, et al.. (2005). [Progress in endoscopic surgery for breast cancer].. PubMed. 32(9). 1240–3. 2 indexed citations
15.
Sakaguchi, Koichi, Hiroo Nakajima, Naruhiko Mizuta, et al.. (2005). Selective cytotoxicity of ascochlorin in ER-negative human breast cancer cell lines. Biochemical and Biophysical Research Communications. 329(1). 46–50. 16 indexed citations
16.
Sawai, Kiyoshi, et al.. (2004). [Key issues in sentinel node biopsy for breast cancer].. PubMed. 31(8). 1271–4. 1 indexed citations
17.
Kitamura, Yoshihiro, Satoru Hashimoto, Naruhiko Mizuta, et al.. (2001). Fas/FasL-dependent Apoptosis of Alveolar Cells after Lipopolysaccharide-induced Lung Injury in Mice. American Journal of Respiratory and Critical Care Medicine. 163(3). 762–769. 265 indexed citations
18.
Chang, Young‐Chae, Hiroo Nakajima, Sharon Illenye, et al.. (2000). Caspase-dependent apoptosis by ectopic expression of E2F-4. Oncogene. 19(41). 4713–4720. 11 indexed citations
19.
Nakajima, Hiroshi, Ikuya Fujiwara, Naruhiko Mizuta, et al.. (1999). FasL expression on pig cells suppresses human natural killer cell mediated-cytotoxicity. Transplantation Proceedings. 31(7). 2704–2706. 2 indexed citations
20.
Yoshimura, Norio, Oka T, Yoshihiro Ohmori, et al.. (1998). Combination Therapy of Tacrolimus (FK506) With Azathioprine and Steroids in Renal Transplant Recipients. Transplantation Proceedings. 30(1). 33–35. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Huifang Zhou Breakdown of academic impact, for papers by Nadia Kourda Breakdown of academic impact, for papers by Zhifang Jia Breakdown of academic impact, for papers by Andrea Beer Breakdown of academic impact, for papers by Oksana Kowalczuk Breakdown of academic impact, for papers by Chun‐I Wang Breakdown of academic impact, for papers by Ying Tian Breakdown of academic impact, for papers by Xiaojun Zhu Breakdown of academic impact, for papers by Uwe Ramp
Rankless by CCL
2026